(
513
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Asthma management during the COVID-19 pandemics
-
Asthma phenotypes in children
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
Benralizumab in severe eosinophilic asthma… Or is it something else?
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
Biologicals in asthma
-
Biologicals in asthma – from clinical trials to real life
-
Biologicals in asthma – from clinical trials to real life
-
Breathomics in asthma diagnosis
-
COVID-19 and virus-induced asthma in children: Asian vs western perspectives
-
Difficult to control asthma in adults
-
Difficult to control asthma in children
-
Does pediatric asthma primarily depend on submicrone aerosol pollutants?
-
Dupilumab improves asthma control and health-related quality of life in children with uncontrolled persistent asthma: VOYAGE study
-
EAACI & ERS joint symposium: new ERS clinical guidelines on diagnosis of asthma in school children
-
EAACI & KAAACI joint symposium: navigating the universe of eosinophilic inflammation in asthma
-
EAACI & WAO joint symposium: World Allergy Forum severe food allergy update
-
Endotype-driven interventions in asthma
-
Environmental influences on allergy and asthma development
-
Environmental influences on allergy and asthma development – what is detrimental?
-
Environmental science in allergy and asthma
-
Flash Talks on asthma and biologicals
-
Flash talks on asthma
-
Flash talks on asthma II
-
Flash talks on asthma treatment
-
How can we improve the quality of life of patients with severe food allergy?
-
How to select and follow a biological for asthma and CRSwNP
-
Implementation of telehealth in asthma management: trials and tribulations
-
Late onset T2 asthma – a case study
-
Management of asthma exacerbations
-
Metabolic changes in the prediction of severe anaphylactic reactions
-
New Epidemiologic Factors Related to allergy and asthma
-
Novel analytical tools to endotype asthma and allergic diseases
-
Novel therapeutic targets in allergic diseases and asthma – from common clues to a universal solution
-
Occupational allergy and asthma to animals – Recent developments
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
The role of EGR-1 as a potential biomarker in asthma and proinflammatory responses in airway epithelium
-
Time for innovation: what can we learn from OMICs about asthma metabolic dysfunction?
-
Updates in [severe] asthma in adults
-
Viral infection and asthma
-
What do clinical trials and real world tell us about allergy and asthma treatment?
-
Allergic severe asthma and cat epithelia in COVID-19 pandemic: a case report
-
Asthma endotypes as risk factors for severe COVID-19 manifestations
-
Biological severe asthma treatment in Poland – pros and cons of drug programme
-
Bronchiectasis and severe asthma
-
Diagnosis and allocation to biologics in severe asthma – guidelines of the Polish Society of Allergology
-
Dupilumab and live-attenuated vaccines: experience with prior dupilumab use and yellow fever vaccine in patients with severe asthma from Brazil
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
Electronic Health in Severe Asthma
-
Focus on Patient. Personalised therapy for severe asthma
-
Immunotherapy in severe asthma (AIT)
-
Novel therapeutic approaches in severe asthma
-
Opportunities and Obstacles to treat severe asthma with new biologics based on experiences from real world practice
-
Severe Asthma and COVID-19
-
The basics of severe asthma – biomarkers
-
The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps
Show more Event Resources (54)Show Less-
-
APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort
-
ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – an EAACI‐ARIA position paper
-
Association between asthma and clinical mortality/morbidity in COVID‐19 patients using clinical epidemiologic data from Korean Disease Control & Prevention
-
Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2
-
Asthma control, self‐management and healthcare access during the COVID‐19 epidemic in Beijing
-
Atopic status protects from severe complications of COVID‐19
-
Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19
-
Characterization of asthma and risk factors for delayed SARS‐CoV‐2 clearance in adult COVID‐19 inpatients in Daegu
-
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort
-
DGAKI statement on asthma and COVID-19
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines
-
Position statement of expert panel of the Polish Allergology Society (PTA) on the management of patients with bronchial asthma and allergic diseases during the SARS-CoV-2 pandemic
-
Real‐life impact of COVID‐19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma Section
-
Risk factors for severe and critically ill COVID-19 patients: A review
-
Association of endopeptidases, involved in SARS‐CoV‐2 infection, with microbial aggravation in sputum of severe asthma
-
COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments
-
Shielding against SARS-CoV-2 infections is not justified in children with severe asthma 
-
Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: results from the Italian Severe Asthma Registry
Show more Covid-19 (16)Show Less-
-
Breaking new ground: A closer look at Type 2 Inflammation in pediatric asthma
-
Can we break the cycle of lung function decline and asthma exacerbations driven by type 2 inflammation in asthma?
-
Championing change: Is elimination of oral corticosteroid use in asthma achievable today?
-
Childhood Asthma and the Impact of Type 2 Inflammation
-
Filling the gaps in asthma care
-
IL-5 inhibition in CRSwNP and severe asthma: impact beyond the eosinophil
-
IgE in asthma and nasal polyposis: your questions answered
-
Pediatric Severe Asthma: Why Lung Function Matters
-
Relegating OCS to last resort: Creating a paradigm shift in asthma management
-
Severe type 2 asthma: phenotypes and precision treatment for patients
-
Strengthening the immune system to reduce asthma risk: paving the way to the future?
-
TSLP: a key epithelial cytokine at the top of the asthma inflammatory cascade
-
Targeting eosinophils in severe asthma: real-world data and clinical remission
-
A unified approach: Improving patient outcomes in severe asthma and comorbid eosinophilic diseases
-
Managing severe asthma and CRSwNP: Through the lens of Type 2 Inflammation
-
Targeted therapy for patients with severe eosinophilic asthma – an interactive conversation with experts
Show more Sponsored Symposia (14)Show Less-
-
Clinical diagnosis and management of severe cutaneous adverse drug reactions (SCARs) in children: an ENDA/EAACI pediatric task force report
-
European network for the PHenotyping of OCcupational ASthma – E-PHOCAS-Phase II 2024
-
Exercise and physical activity for asthma management: an EAACI task force position paper
-
Immunometabolism in allergy and asthma – AllerIMMET
-
Joint Task Force on the role of residential greenness exposure in the multifactorial pathway towards allergy and asthma (EAACI statement)
-
Managing the upcoming increase in asthma prevalence cause by the war in Ukraine
-
Occupational Mite Allergy and Asthma (OMAA)
-
Phenotypes and endotypes of pediatric asthma
-
Prevalence and predictive factors for co-morbid CRS and asthma
-
Prevalence and predictive factors for co-morbid CRS and asthma
-
Principles for targeting eicosanoids in the treatment of asthma and allergic diseases
-
Public outreach for immunological mechanisms in allergies and asthma
-
Severe atopic dermatitis associated with hypogammaglobulinemia
-
The new nomenclature for allergic diseases and asthma
-
The use of omic sciences in asthma and allergy clinical practice
-
Therapeutic education for patients with asthma
-
Under- and over-diagnosis of asthma
Show more Task Forces (15)Show Less-
-
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paper
-
A survey study on antibiotic prescription practices for acute asthma exacerbations: An European academy of allergy and clinical immunology task force report
-
A systematic review and meta-analysis on absolute eosinophil counts and the risk of asthma in preschool children with wheezing: An EAACI Task Force Report
-
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)
-
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA Position Paper
-
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position Paper
-
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
-
EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthma
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
-
Omics technologies in allergy and asthma research: An EAACI position paper
-
Perceptions of adolescents and young adults with allergy and/ or asthma and their parents on EAACI guideline recommendations about transitional care: A European survey
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research – The European Strategic Forum on Allergic Diseases
-
The One Health approach for allergic diseases and asthma
-
Influenza burden, prevention, and treatment in asthma – A scoping review by the EAACI Influenza in asthma task force
Show more Position Papers (12)Show Less-
-
EAACI Biologicals Guidelines – Treatment with biologicals for severe chronic rhinosinusitis with nasal polyps
-
EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma
-
EAACI Guidelines on the effective transition of adolescents and young adults with allergy and asthma
-
EAACI guidelines on environmental science in allergic diseases and asthma
-
EAACI Biologicals Guidelines – Recommendations for severe asthma
Show more Guidelines (3)Show Less-
-
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)
-
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA position paper
-
ERS/EAACI statement on adherence to international adult asthma guidelines
-
The One Health approach for allergic diseases and asthma
Show more Consensus Documents (2)Show Less-
Website
Collapse
-
“In Class Cross-Reactivity” to all tested cephalosporins revealed in a patient with Cefazolin-induced Severe Cutaneous Adverse Drug Reaction
-
131 genetic loci highlight immunological pathways and tissues in asthma and nasal polyposis
-
17q21 locus rs7216389 polymorphism and asthma risk: a meta-analysis
-
A Rare case of purine nucleoside Phosphorylase deficiency (PNP) Severe combined Immunodeficiency (SCID)
-
A case of life-threatening asthma triggered by mood disorder and sexual abuse
-
AI-derived trajectories of wheezing and asthma in children: a systematic review
-
Absence of alpha-tryptase isoforms is associated with less severe adverse events during peanut-oral immunotherapy
-
Absence of alpha-tryptase isoforms is associated with less severe allergic reactions at food challenge to peanut
-
Accuracy of changes in fractional exhaled nitric oxide for diagnosing occupational asthma
-
Adherence to a sustainable and healthy dietary pattern and its impact on asthma and airway inflammation
-
Adherence to a sustainable and healthy dietary pattern and its impact on asthma and airway inflammation
-
Advancing Asthma Diagnosis: Integrating Exhaled Biomarkers and Deep Neural Networks (DNNs) in a POC Breath Test
-
Advancing Asthma Diagnosis: Integrating Exhaled Biomarkers and Deep Neural Networks (DNNs) in a POC Breath Test
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergenicity of eight soy products: allergy to soy dairy is most frequent and most severe
-
Allergic asthma
-
Allergic asthma – a challenge no more
-
Allergy asthma and a sport
-
Analysis of exacerbating factors of pediatric asthma before and after the COVID19 pandemic
-
Anaphylaxis and other severe paediatric allergies in Finland and Sweden between 2012-2020
-
Application of Smart Wearable Devices in Management of Asthma
-
Apply cluster analysis and machine learning to identify phenotypes of work-related asthma
-
Approaching CRSwNP and asthma with biologicals – RWE data
-
Association between 25-hydroxy vitamin D and pulmonary function among obese and asthma children
-
Association between 25-hydroxy vitamin D and pulmonary function among obese and asthma children
-
Asthma
-
Asthma & Biologicals
-
Asthma 1
-
Asthma 2
-
Asthma 3
-
Asthma 4
-
Asthma 5
-
Asthma 6
-
Asthma 7
-
Asthma 8
-
Asthma 9
-
Asthma Digital Health Tools and Opportunities for ArtificiaI Intelligence – Based Risk Prediction
-
Asthma Right Care – the growth of the social movement to reduce reliance on episodic care and to increase long term safe and person-centred care
-
Asthma and Climate Change: A Five Year Study of Camp Wheez
-
Asthma and comorbidities
-
Asthma and nutrition
-
Asthma endotypes in the era of data science boom!
-
Asthma exacerbations and death after recovery from COVID-19: A nationwide long-term follow-up study
-
Asthma exacerbations in the pediatric emergency area: evaluation and prospects for improvement of pre-hospital care
-
Asthma in Brazilian children and adolescents
-
Asthma in the Intermediate/Intensive Care of a Central Hospital
-
Asthma is associated with increased sickness absence among young adults
-
Asthma phenotype markers did not affect allergen immunotherapy effectiveness
-
Asthma remission: what is it and how can it be achieved?
-
Asthma response in patients with allergic rhinoconjunctivitis to grass pollen using an environmental exposure chamber
-
At the core of allergy and asthma pathology: exploring the connection between airway epithelium and effector cells
-
Atipical horchata allergy: case report and mollecular study in pacient with severe reaction due to horchata
-
Baseline Disease Characteristics Among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA Registry
-
Baseline IgE Levels Predict an Unstable Disease Course in Adults With Severe Atopic Dermatitis That is Stabilized by Dupilumab Therapy
-
Best tools for allergy and asthma translational research
-
Biologics have Solved the Problem of Type 2 Asthma
-
Biomarker-guided approach for treatment of preschool asthma
-
Breast-feeding is inversely associated with asthma and IgE sensitisation up to young adulthood
-
Briquilimab, an Anti-Human CD117 Antibody, Effectively Treats Cockroach Allergen-Induced Asthma Model Elicited in Mice Expressing Chimeric Human/Mouse CD117
-
Bronchiolitis and future risks for childhood asthma
-
Burden and subtypes of early-life infections increase the risk of asthma and adverse lung function
-
Case report of an occupational disease in a veterinarian with allergic asthma
-
Changes in the awareness on anaphylaxis and asthma exacerbation: Education for 119 emergency department paramedics in Korea
-
Characterization of Patients With Asthma Initiating Dupilumab Treatment in a Real-World Setting: The RAPID Registry
-
Chemical product exposure in professional cleaners and its relationship with occupational asthma
-
Childhood asthma and allergy is related to accelerated epigenetic aging in the LISA birth cohort
-
Clinical experience with newer systemic treatment for moderate to severe atopic dermatitis in children and adolescents: a single-centre study
-
Clinical outcomes used in allergen immunotherapy in allergic asthma in the era of Data Science
-
Clinical trials on Asthma and Rhinitis
-
Common variable immunodeficiency in severe asthma; (Coexistence or coincidence?)
-
Comparative Risk of Neuropsychiatric Adverse Events Associated With Leukotriene-Receptor Antagonists Versus Inhaled Corticosteroids Among Asthma Patients
-
Comparison of the efficacy of subcutaneous and sublingual immunotherapy for the treatment of allergic asthma in children
-
Correlation between Fractional exhaled nitric oxide and pulmonary function test in children with asthma
-
Correlation between the timing of allergenic foods introduction and severe allergic reactions: monocentric retrospective Italian study
-
Correlation between the timing of allergenic foods introduction and severe allergic reactions: monocentric retrospective Italian study
-
Cracking the code on asthma prevention
-
Cross-allergy to defensins as an important cause of severe food allergy – a series of 4 cases of recurrent life-threatening food anaphylaxis following digestion of food containing plant-derived ingredients
-
Cytometric detection of Der p 1 and Der p 2 binding to Basophils (CytoBas) enables precise determination of house dust mite sensitization in patients with asthma and allergic rhinitis
-
Cytometric detection of Der p 1 and Der p 2 binding to Basophils (CytoBas) enables precise determination of house dust mite sensitization in patients with asthma and allergic rhinitis
-
Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of tezepelumab in adult patients with severe chronic rhinosinusitis with nasal polyposis (WAYPOINT)
-
Developing a quality of life outcome measure for paediatric severe asthma: a qualitative study
-
Diagnosing Asthma with an Exhaled Breath Test at the Point of Care (POC)
-
Diagnosis of allergic asthma
-
Differential study of whole genome expression profiles of peripheral blood mononuclear cells in children with dust mite specific immunotherapy for asthma
-
Dual monoclonal antibody therapy in a patient with chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma: a case report and proteome analysis
-
Dupilumab Reduces FeNO levels and Exacerbations and Improves Asthma Control with Inhaled Corticosteroid Withdrawal: a Phase 2 Study
-
Dupilumab Reduces Systemic Corticosteroids in Children With Uncontrolled Moderate-to-Severe Asthma Regardless of Exacerbation History
-
Dupilumab dose reduction in controlled severe atopic dermatitis and predictive factors
-
Dupilumab dose reduction in controlled severe atopic dermatitis and predictive factors
-
Dupilumab in Pediatric Patients with Severe Atopic Dermatitis: A Pilot Study
-
EAACI & IPCRG Joint Symposium : Improving the Delivery of Person-centred asthma care in global primary care
-
EAACI nomenclature for allergy and asthma
-
Effects of dupilumab on quality of life and airflow obstruction in refractory type 2 high severe unified airways disease
-
Efficacy of Rilzabrutinib on Asthma Control: Results From a Double-Blind Placebo-Controlled Phase 2 Study
-
Efficacy of Rilzabrutinib on Asthma Quality of Life: Results From a Double-Blind Placebo-Controlled Phase 2 Study
-
Eosinophilia over dupilumab treatment in asthma patients: a multicentric retrospective study
-
Epigenome-wide association study of asthma exacerbations in European populations
-
Evaluating the relevance of measurement tools in assessing the effectiveness of 12 SQ HDM SLIT-tablet for Chinese patients with moderate to severe house dust mite allergic rhinitis with or without allergic asthma: a prospective observational study
-
Evolving understanding of IL-5: pleiotropic effects and clinical relevance in asthma and CRSwNP
-
Exosomal Signaling and Mitochondrial Transfer Reprograms T Helper Cell Function in Human Asthma
-
Exploring the Potential of Serum Periostin and YKL-40 as Airway Remodeling Markers for Airway Hyperresponsiveness in Pediatric Asthma
-
Exploring the impact of oncologic risk factors on severe COVID-19 outcomes through multiplatform metabolomics
-
Exploring the impact of oncologic risk factors on severe COVID-19 outcomes through multiplatform metabolomics
-
Flash talks on Asthma
-
Flash talks on Asthma
-
Flash talks on Pediatric Asthma
-
Frequency of asthma exacerbations in Mexican patients with Vitamin D insufficiency/deficiency and dyslipidemia
-
From suspected poorly controlled asthma to allergic bronchopulmonary aspergillosis
-
GSK – Evolving understanding of IL-5: pleiotropic effects and clinical relevance in asthma and CRSwNP
-
Genetic polymorphisms associated with the development of asthma in the Kazakh population
-
Genome-wide association study identifies CACNA2D3 associated with asthma and atopic dermatitis multimorbidity in children
-
Global Initiative for Asthma (GINA) Guidelines
-
Group A – Asthma
-
Gut Microbiota and Phenotypes of Childhood Asthma
-
Health Care Situation in the Treatment of Uncontrolled GINA 4/5 Asthma Patients in Germany: 2019 vs. 2022
-
Hereditary angioedema and severe chronic urticaria, what the odds?
-
Hot Topics in Pediatric Asthma
-
House dust mite sublingual immunotherapy comprehensively improves asthma and allergic rhinitis in children and adolescents
-
How should I manage co-morbidities in severe asthma?
-
Human milk oligosaccharides 3’SL and 6’SL suppress airway hyperreactivity, while only 3’SL also reduces airway inflammation in a murine allergic asthma model
-
Hypoallergenic and anti-remodeling effect of a hybrid protein in a murine model of chronic asthma induced by Dermatophagoides pteronyssinus
-
IL-13 and airway calibre codetermine exhaled nitric oxide levels in type-2 asthma patients
-
Identification of novel fusion transcripts as potential biomarkers of severe allergy using RNA extracted from platelets
-
Identification of novel fusion transcripts as potential biomarkers of severe allergy using RNA extracted from platelets
-
Immune pathways impairment in severe atopy: the lesson learned from primary atopic disorders
-
Immuno-metabolic reprogramming of bronchial epithelium in asthma
-
Immuno-metabolic reprogramming of bronchial epithelium in asthma
-
Immunologic profile and safety of milk oral immunotherapy in children with severe cow’s milk allergy – a series of cases
-
Immunological and molecular characterization of a cohort of patients with severe atopic dysregulation in suspected or diagnosed Inborn Errors of Immunity
-
Immunological changes induced by a salsola kaly extract in patients with allergic rhinitis or rhinitis and asthma
-
Impact of Asthma on Hospitalization and Antibiotic Courses in Common Variable Immunodeficiency Respiratory Infections
-
Impact of a 3-tree sublingual immunotherapy liquid formulation in birch family pollen-allergic patients on prevention of disease progression and/or asthma onset
-
Impact of asthma as a chronic disease on the quality of life of the patient and his family
-
Impact of liquid sublingual immunotherapy on asthma worsening prevention: GINA treatment stepping up results from the real-world EfficAPSI study
-
Impact of liquid sublingual immunotherapy with mixed pollen allergens on asthma prevention in polyallergic patients: results from the real-world EfficAPSI study
-
Impact of mepolizumab on exacerbations and maintenance OCS use in patients with asthma and baseline blood eosinophil counts of ≥150–<300 cells/μL in the REALITI-A study: 2-year outcomes
-
Inflammatory and Oxidative Stress Markers in Serum, Urine and Exhaled Breath Condensate: Relationship between Asthma and Obesity in Children
-
Inflammatory cytokine-mediated airway remodeling in asthma
-
Influence of selected cytokines and chemokines on the ventilation efficiency in spirometric examination, in patients with asthma post-COVID-19
-
Inhaled corticosteroid-related neuropsychiatric side effects in children with asthma
-
Integrating Breathomics with CPET: A Breath-Taking Approach to Exercise-Induced Asthma Monitoring
-
Interindividual variability in serum concentration of montelukast and metabolites in asthma patients
-
Investigating the Role of TBXA2R rs4523 Gene Polymorphism Associated with Asthma among Population of West Bengal, India
-
Investigation Of Treatment Responses And Clinical Characteristics Of Patients With The Late-Onset Asthma Phenotype Under Biological Treatment
-
Investigation of the inflammatory profile in tears of severe atopic dermatitis patients treated with dupilumab. A study of the BIOBADALER consortium
-
Investigation of the inflammatory profile in tears of severe atopic dermatitis patients treated with dupilumab. A study of the BIOBADALER consortium
-
Investigation of the predictors of asthma phenotypes (atopic and non-atopic asthma) using machine learning and traditional statistical techniques
-
Involvement of Janus kinase (JAK)-dependent Bcl-xL overexpression in steroid resistance of group 2 innate lymphoid cells (ILC2s) in asthma
-
Is Mediterranean Diet Best for Asthma Prevention?
-
Levels of total IgE vs. specific IgE during childhood for defining and predicting T2-high asthma
-
Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Reducing Infectious Events in Allergic Rhinitis Patients with and without Asthma
-
Long-term dupilumab effect on lung function in subgroups of pediatric patients with uncontrolled asthma
-
Long-term immune response accompanies clinical outcomes in severe asthmatics treated with anti-IL-5/IL-5R biologics
-
Long-term outcome of work-related asthma
-
Low education level, occupational exposure and no medication use increase the risk of uncontrolled asthma in Chinese patients: findings from baseline data of a multi-centre, single-arm study (CARE FOR ALL)
-
Lung Function Improvement is Associated With Better Asthma Control in Adolescents and Adults Aged 12 Years and Older With Moderate-to-Severe Type 2 Asthma: A Post Hoc Analysis of QUEST
-
Lung Function Responder Rates in the VOYAGE study in Children with Moderate-to-Severe Type 2 Asthma Receiving Dupilumab at Week 52
-
Management of allergic asthma
-
Maternal exercise during pregnancy is associated with reduced risk of asthma in the child: a prospective birth cohort study
-
Measurement of serum specific IgE to Ryegrass allergen component Lol p 5 in the TAISAR cohort predicts risk of Thunderstorm Asthma
-
Measuring adherence to inhaled asthma controller medication
-
Mechanisms and Predictors of Response or Failure to Biologic Therapies in Asthma and Allergy
-
Metabolome analysis of T effector and T regulatory cells from severe pollen allergic patients, a pilot study
-
Model-based machine learning to understand progression of asthma through life-course
-
Moderate-High Blood Eosinophilia Is Associated with Increased Hospitalization and Other Asthma Comorbidities
-
Monitoring for early warning signs of asthma attacks and response to treatment with oral corticosteroids using the Albus Home contactless monitoring system
-
Monocyte chemotactic factors in the airways of patients with asthma after an allergen challenge
-
Navigating the asthma maze in children: insights into phenotypes, innovative treatments, and preventive measures
-
Novelties in asthma Biomarkers and immunomodulatory pathways
-
OAS3: ENT, asthma and respiratory allergy
-
Obesity Modified the Genetic Effect on Risk of Asthma: A Genome-wide Association Study of Adult Asthma
-
Omalizumab administration for the management of severe allergic keratoconjunctivitis – a 10-year experience
-
Omalizumab in children with allergic severe asthma, food allergies and IgE Levels >1,500 kU/L: a two-year-long evaluation
-
Omalizumab to the rescue for severe anaphylaxis in desensitization to carboplatin
-
Omega-5 gliadin allergy as a cause of severe anaphylaxis in non-atopic patients
-
Optimising asthma management in children
-
Optimising support for patients with asthma – a primary care model
-
Oral Immunotherapy with omalizumab in an adult patient with severe milk and egg allergy
-
Overview of Asthma On-Treatment Clinical Remission Data
-
PDS9: Asthma
-
Parasitic Infection as a risk factor for Childhood Asthma in Upper Egypt
-
Patients With Moderate-to-Severe Asthma Treated With Dupilumab Are More Likely to Meet Clinical Remission Criteria: Results From the VESTIGE Trial
-
Patients undergoing immunotherapy with Alternaria alternata: prevalence of asthma and co-sensitization to other allergens
-
Perceived Impact and Awareness of Climate Change among Climate-Vulnerable Adults with Asthma
-
Perseverance in Asthma Education: Controlling Frequent Wheezing in a schoolgirl
-
Personalized application of Biologics in pediatric allergy and asthma
-
Practical Guide to Biomarker-Driven Pediatric Asthma Management
-
Predicting the Efficacy of Allergen Immunotherapy in Asthma Based on Initial-Year Outcome: Insights from the Estimated Daily Symptom and Medication Score
-
Predictors of Exacerbation-Prone Asthma in children: comorbidities and T2 Biomarkers with allergy sensitization
-
Predictors of Treatment Response to Biological Therapy in Patients with Severe Asthma: Insights from Induced Sputum Analysis
-
Prevalence and causes of AR and asthma in Mongolia
-
Prevalence and impact of allergic comorbidities in patients with severe atopic dermatitis in treatment with Dupilumab
-
Prevalence of Severe Atopic Dermatitis and Comorbid Chronic Systemic Diseases is Increasing in Korean Children and Adolescents
-
Prevalence of asthma as comorbidity in uncontrolled CRSwNP prior to endoscopic sinus surgery – a cross-sectional study
-
Prevention of allergic asthma
-
Probiotics Supplementation on mitigating adverse effects of Phthalate-Induced Asthma
-
Proposal of an algorithm for asthma diagnosis using molecular biomarkers
-
RHINA : What can we learn from the asthma guidelines
-
Raising the Bar in Asthma Management: On-Treatment Clinical Remission
-
Real-Life effectiveness of a Cohort of Patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) and Concomitant Moderate Persistent Asthma Treated with Dupilumab
-
Real-life efficacy of dupilumab in patients with asthma phenotype overlap- data from a tertiary pulmonary centre
-
Real-world clinical experience with dupilumab use in 33 children with severe atopic dermatitis
-
Real-world efficacy of dupilumab as a second-line treatment in severe asthma- data from a tertiary pulmonary centre
-
Reduced Allergic Asthma By Soy And Its Potential Mechanism Via Plasminogen Activator Inhibitor-1
-
Reimagining Severe Asthma: From Control to Remission
-
Relationship Between Disease Control, Oxidative Stress And Diet In Adolescent Asthma Patients
-
Relationship Between Disease Control, Oxidative Stress And Diet In Adolescent Asthma Patients
-
Respiratory muscle functions in asthma
-
Response to benralizumab in severe vernal keratoconjunctivitis after treatment failure with omalizumab
-
Role of sublingual immunotherapy in management of patients with moderate to severe allergic rhinitis; one year study
-
Role of the single nucleotide variants of filaggrin, thymic stromal lymphopoietin and orsomucoid-1-like protein 3 in the development of atopic bronchial asthma phenotypes in children
-
Root and branch of childhood asthma management
-
SQ house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet is well-tolerated in children with inadequately controlled HDM allergic asthma
-
Safety of dupilumab in patients with severe asthma: real-life experience
-
Serial fractional exhaled nitric oxide measurements at and off work: usefulness for diagnosis and tertiary prevention of occupational asthma
-
Serum Periostin Level Predicted Length of Hospital Stay in Patients with Allergic Asthma
-
Severe Atopic Dermatitis and HyperEosinophilic Syndrome in Children Undergoing Dupilumab Treatment: Report of two cases
-
Severe Milk Allergy: Outcame of OIT with Omalizumab in a Real Life setting. Seven years follow up
-
Severe atopic dermatitis and upadacitinib: tertiary care outpatient experience
-
Severe atopic dermatitis: a stand-alone disease or something more?
-
Severe cholinergic urticaria, it runs in the family
-
Sex differences in childhood asthma are driven by a T2-high phenotype and mediated through sex-hormone metabolites
-
Sex differences in childhood asthma are driven by a T2-high phenotype and mediated through sex-hormone metabolites
-
Skin microbiome dynamics as predictor and pathogenesis mechanism for severe radiodermatitis in breast cancer patients
-
Stop omalizumab in a pediatric population with severe asthma: A retrospective monocenter study
-
Successful Rapid Desensitization with Atezolizumab after severe hypersensitivity reation in a patient with small-cell lung metastatic cancer: a case report
-
Successful rapid drug desensitization with adrenaline infusion pump in severe allergic reactions
-
Sympout study: Effectiveness of a sublingual allergen extract in liquid formulation standardized in TBU/ml in patients with bronchial asthma due to house dust mites or pollens
-
Sympout study: Need of medication for symptom control in patients with rhinitis and/or bronchial asthma due to house dust mites or pollens in treatment with sublingual immunotherapy in a standardized liquid formulation in TBU/ml
-
Targeted drug-induced apoptosis in key cellular mediators of allergic asthma as a new treatment strategy
-
Tests to Diagnose Asthma
-
The Effectiveness of Educational Interventions on Asthma Management in Children in Primary care settings: Systematic Review of Randomised Control Trials
-
The Eosinophil in Obstructive Airway Disease – Beyond Asthma
-
The HMOS 2’FL and 3FL prevent house dust mite induced proinflammatory cytokine release in vitro and decrease HDM-specific IgE in an allergic asthma murine model
-
The Impact of Excess Weight and Obesity on Asthma Control in a Pediatric Population
-
The SQ HDM SLIT-tablet is effective and well-tolerated in children (5-11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis with and without concomitant asthma – results from a global phase III clinical trial
-
The Use of Long-acting Muscarinic Antagonist (LAMA) in the Treatment of Asthma: A Tertiary Asthma Center Experience
-
The burden of allergic diseases and asthma – results from the HEAD registry
-
The burden of severe asthma: the patient’s perspective
-
The dynein adaptor Hook2 as microtubule-based transport and anchors for organelles is involved in asthma pathogenesis
-
The effect of tezepelumab treatment on the incidence of asthma exacerbations co-occurring with acute respiratory illnesses attributed to infections: results from a pooled analysis of the PATHWAY and NAVIGATOR studies
-
The effect of therapies targeting Type 2 inflammation on Neutrophil Extracellular Traps (NETs) and Extracellular Eosinophilic Traps (EETs) in severe CRSwNP
-
The effect of therapies targeting Type 2 inflammation on Neutrophil Extracellular Traps (NETs) and Extracellular Eosinophilic Traps (EETs) in severe CRSwNP
-
The effectiveness and safety of Abrocitinib treatment for severe atopic dermatitis in the real-world data in Turkey
-
The gut fungome is associated with future risk of exacerbations, asthma control and quality of life in children with uncontrolled asthma: results from the PUFFIN study
-
The impact of Type 2- targeted biological therapies on persistent cough in adults with cough variant- or cough predominant asthma
-
The impact of asthma and mental health condition multimorbidity in national samples of Canadian children
-
The impact of second-hand exposure to e-cigarette on asthma exacerbations in the pediatric population
-
The interaction of atopy and reduced biodiversity of upper airway microbiome promotes higher nasal expression of IL-5 and asthma persistence in early childhood
-
The interaction of atopy and reduced biodiversity of upper airway microbiome promotes higher nasal expression of IL-5 and asthma persistence in early childhood
-
The m6A demethylase FTO mediates type 2 inflammation in asthma by regulating STAT6 mRNA stability
-
The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps
-
The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps
-
The new nomenclature for asthma and allergy
-
The parasympathetic nervous system plays a key role in control and stress in patients with asthma
-
The potential of anti-infectives and immunomodulators in pediatric asthma
-
The puzzling journey of asthma diagnosis – the IPCRG’s new educational approach.
-
The significance of FeNO test in patients with different asthma endotypes
-
The triple type 2 signature is associated to asthma severity and comorbidity with CRS
-
Towards a Treat to Target approach in asthma: Asthma remission
-
Triggers and Mechanisms of Asthma Exacerbations: One Outcome, Many Paths?
-
Tumor necrosis factor-alpha in allergic inflammation in overweight children with asthma
-
Unique effect of aspirin on bronchial 15-oxo-ETE levels in patients with asthma and aspirin hypersensitivity
-
Unique effect of aspirin on bronchial 15-oxo-ETE levels in patients with asthma and aspirin hypersensitivity
-
Unique role of Candida albicans sensitization in management of asthma patients living underground during military operations in Ukraine
-
Unmet needs in severe allergic rhinitis
-
Use of dupilumab in two pregnant women with nasal polyposis and severe persistent asthma: two case reports
-
Use of the AllergyVax Doctor app to evaluate the correlation between adherence to treatment and control of rhinitis and asthma in patients during treatment with SLIT
-
Vitamin D3 deficiency is more common in children with asthma than in children with other allergic diseases
-
Voice biomarkers: a new tool for asthma management
-
What are the predictors of asthma remission and what can we modify?
-
What is asthma remission and what can we learn from other autoimmune and inflammatory disease about remission?
-
When and how it starts: unveiling the early development of asthma in preschool years
-
Which biological should I use for severe asthma?
-
A 12 months real-life prospective study of lung function in patients with severe eosinophilic asthma undergoing therapy with ics/laba, lama, and anti IL5/5R monoclonal antibody
-
A proof-of-concept study on an artificial intelligence model for biological therapy decision-making in severe asthma
-
A proof-of-concept study on an artificial intelligence model for biological therapy decision-making in severe asthma
-
Adverse reactions to biologicals in severe asthma
-
Allergen immunotherapy in patients with allergic rhinitis and asthma associated with reduced risk of severe COVID-19
-
Allergy and Asthma – Session 1: Diagnosing Asthma
-
Allergy and Asthma – Session 2: Precision medicine in pediatric asthma
-
An interim analysis of a multi-center, oPEn label, Randomized study to investigate the saFEty of an optimal acCelerated scheme for immunoTherapy in adolescent and adult patients with moderate to severe AR with or without asthma in China. (PERFECT)
-
Assessing Disease Activity to Better Define On-Treatment Clinical Remission in Pediatric Severe Asthma
-
Association of asthma severity with high sensitivity C-reactive protein (hsCRP) in the all-age asthma cohort ALLIANCE
-
AstraZeneca – Transforming severe asthma respiratory care: the clinical experience
-
Baseline Characteristics of Patients with Severe Asthma in Spain according to biological treatment use: BREATHE study
-
Baseline disease burden in severe asthma patients treated with biologics, and eligible but not treated: Spanish patients in the ISAR Registry
-
Benralizumab effectiveness in severe eosinophilic asthma patients from Central Eastern Europe and Baltics: BREEZE study
-
Causes of death in patients diagnosed with severe asthma in our area- 10 years observational study
-
Clinical Characteristics of Patients with Severe Asthma by Different Elevated Biomarkers Classifications: Patients from Spain in the ISAR Registry
-
Clinical effects of dupilumab in patients with rhinosinusitis, nasal polyposis, and severe uncontrolled asthma with t2 phenotype, after 12 months of treatment
-
Clinical implications of biologic therapies in comorbid severe asthma and CRSwNP
-
Clinical profile of 457 Latin-American severe asthma patients in Mexico: differences between those who are and those who are not on biologics (OMA, DUPI, anti-IL5)
-
Comprehensive Analysis Of Pediatric ICU Admissions For Severe Acute Asthma Over A Decade
-
Dupilumab-induced skin reaction in a patient with severe asthma and chronic rhinosinusitis with nasal polyposis and without prior skin conditions
-
Effect of baseline long-acting muscarinic antagonist (LAMA) use on inhaled corticosteroid dose reduction in patients with severe eosinophilic asthma treated with benralizumab: SHAMAL post-hoc analysis
-
Efficacy of Dupilumab in patients over 50 years of age with severe asthma
-
Elevating patient treatment outcomes in Severe Asthma
-
Elevating patient treatment outcomes in Severe Asthma & comorbid CRSwNP
-
Emerging therapies and approaches for achieving remission in severe asthma
-
Evaluation of remission of Severe Asthma treated with monoclonal antibodies according to different definitions: a single center cohort
-
Evaluation of the Pediatric Patients with Severe Eosinophilic Asthma Treated with Mepolizumab
-
First clinical practice of using biologic therapy with dupilumab in combination with allergen-specific immunotherapy in a patient with severe atopic dermatitis and bronchial asthma
-
GSK – Elevating patient treatment outcomes in severe asthma and CRSwNP
-
Immunodeficiency spectrum in patients with severe asthma receiving biologicals
-
Immunodeficiency spectrum in patients with severe asthma receiving biologicals
-
Impact of asthma on severe food-induced allergic reactions: a systematic review and meta-analysis
-
Indirect case matched comparison of dupilumab versus benralizumab on mannitol airway hyperresponsiveness in type 2 high severe asthma
-
Infective asthma exacerbations in severe asthmatic patients receiving biological drugs
-
Long-Term Efficacy of Mepolizumab at 5 Years in Patients with Severe Asthma
-
Mepolizumab simultaneously improves clinical outcomes in severe CRSwNP and asthma in the SYNAPSE study: Focus on global airway disease
-
Mid-Term Impact of Non-Pharmaceutical Interventions on the Epidemiology of Hospitalizations for Severe Asthma Exacerbation in Children : A Time-Series Analysis
-
Molecular allergen sensitizations drive phenotypes of severe asthma in children: evidence from a megacity cohort (SAMP)
-
Monitoring Patients with Severe Eosinophilic Asthma Receiving Benralizumab in Allergy Centers in Greece for 8-12 months – REALISM-A Study (gReek rEAl Life regIStry of benralizuMab among Allergists)
-
Omalizumab Combined Chinese Traditional Medicine in a Complicated Severe Asthma after Bronchial Thermoplasty
-
OverSEA: European Delphi Consensus Study on Best Practices for patients with Severe Eosinophilic Asthma and comorbid CRSwNP
-
Patients with severe eosinophilic asthma starting anti-IL5 treatment after 2018 have better preserved lung function compared to the patients who started treatment earlier
-
Predictors of biological therapy in severe asthma patients. An ambispective study from the BIOBADALER consortium
-
Predictors of biological therapy in severe asthma patients. An ambispective study from the BIOBADALER consortium
-
Pro-inflammatory cytokines (IL-6 and TNF), influence of the JAK-STAT cascade and negative regulation of the Hyppo pathway in the severe asthma phenotype
-
Progression of Underlying Disease in Pediatric Severe Asthma
-
Progressive increase of the intervals between omalizumab administration in severe asthma
-
Real-life data analysis of severe asthma patients undergoing biologic therapy: OCS consumption and respiratory function evaluation
-
Relevance of IL-17-associated immune pathways and CXCL10 expression in severe childhood asthma
-
Relevance of IL-17-associated immune pathways and CXCL10 expression in severe childhood asthma
-
Retrospective analysis of quantitative CT characteristics of patients with severe asthma treated with biological agents: KoSAR registry
-
Serum Levels of Cytokine in Individuals with Severe Asthma with Obesity
-
Serum cytokine profiles of pediatric normal weight asthma and overweight/obese asthma and their correlation with pulmonary function indices
-
Severe Asthma and Obesity: A retrospective study
-
Severe Eosinophilic Asthma later recognized as EGPA treated with Benralizumab
-
Severe asthma in pediatrics and Dupilumab after failure with Omalizumab
-
Severe asthma or COPD with eosinophilic inflammation? – from uncertainty to remission under anti-IL-5R therapy
-
Stability of steroid-dependent severe asthma during 5-year follow-up
-
Successful treatment of severe asthma after switch of biologics. A case report
-
Successfully managing severe asthma
-
T2 inflammatory profile of 457 Latin-American severe asthma patients in Mexico: differences between those who are and those who are not on biologics (OMA, DUPI, anti-IL5)
-
Targeting TSLP in severe asthma
-
The relevance of IL-5 biology in severe asthma
-
Toward Optimal disease control: impact of maintenance inhaler therapy and device transition in severe asthma patients undergoing monoclonal antibody treatment
-
Transforming severe asthma respiratory care: the clinical experience
-
Treatment of severe asthma (update)
-
Type 2-high airway inflammation in childhood asthma distinguishes a more severe phenotype
-
Use of biologics in severe uncontrolled asthma at National Institute of Pediatrics 2020-2023
-
Use of biologics in severe uncontrolled asthma at National Institute of Pediatrics 2020-2023
-
Variables predicting clinical remission among adults with severe asthma treated with biologic agents
-
Asthma control, lung function, and quality of life in pediatric patients with severe asthma undergoing biological treatment
-
Characteristics of asthma phenotypes: Does coexistence of allergic and eosinophilic asthma increase asthma severity?
-
Decoding Asthma Therapies: Transcriptomic differences between benralizumab and mepolizumab treatment in patients with severe eosinophilic asthma
-
Prevalence of severe fatigue and its contributing factors in patients with severe asthma
-
Real-world change in asthma symptom control and oral corticosteroid use in patients with severe asthma treated with mepolizumab stratified by atopic status: Post hoc analysis of REALITI-A at 2 years
-
Real-world effectiveness of biologics in patients with severe asthma: analysis of the Korean Severe Asthma Registry (KoSAR)
-
Severe asthma and sleep disorders: a Severe Asthma Network Italy (SANI) analysis
-
Characteristics and Asthma Control Status of Severe Asthma Patients in the Korean Severe Asthma Registry-2 (KoSAR-2)
Show more Sessions (352)Show Less-
-
Albania – Albanian Society of Allergy, Asthma and Clinical Immunology (ASAACI)
-
Asia Pacific – Asia Pacific Association of Allergy Asthma and Clinical Immunology (APAAACI)
-
Cuba – Cuban Society of Allergy, Asthma and Clinical Immunology (CSAACI)
-
Iran – Iranian Society of Asthma and Allergy
-
Saudi Arabia – Saudi Allergy Asthma & Immunology Society (SAAIS)
-
Spain – Spanish Pediatric Society of Clinical Immunology, Allergy and Asthma (SEICAP)
-
Turkey – Academy of Pediatric Allergy and Asthma (CAAAD)
Show more Member societies (5)Show Less-